NOVOSOM
Novosom is working with its partners to develop unique antisense, DNAi and siRNA based therapeutics with a current focus in inflammation, oncology and liver diseases. Novosom’s Smarticles® liposomal vectors allow partners to deliver their active substance (siRNA, antisense, decoy etc) inside the cell either for topical or systemic applications. Smarticles are an enabler of systemic treatments and an enhancer of topical treatments. The Company has several active therapeutically-relevant collaborations in oncology and inflammation. Novosom AG main investors include IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH and MBG Mittelständische Beteiligungs-gesellschaft Sachsen Anhalt.
NOVOSOM
Industry:
Biotechnology Health Care
Founded:
1999-01-01
Address:
Halle, Sachsen-Anhalt, Germany
Country:
Germany
Status:
Active
Contact:
+49 345 55 59 836
Similar Organizations
More informations about "Novosom"
Novosom - Crunchbase Company Profile & Funding
Novosom is working with its partners to develop unique antisense, DNAi and siRNA based therapeutics with a current focus in inflammation, oncology and liver diseases. Novosom’s …See details»
Novosom Company Profile 2024: Valuation, Investors, Acquisition
Novosom was founded in 1999. Where is Novosom headquartered? Novosom is headquartered in Halle, Germany. What is the size of Novosom? Novosom has 18 total employees. What …See details»
novosom AG - LinkedIn
Novosom AG is a biopharmaceutical company with a pioneering, fully charge-reversible liposomal technology for the delivery of DNA based therapeutics. novosom's SMARTICLES® allow the …See details»
Novosom AG - Company Profile and News - Bloomberg Markets
Novosom AG operates as a biopharmaceutical company focused on DNA based therapeutics. The Company researches and develops liposomal technology for the delivery of intracellular …See details»
novosom - Products, Competitors, Financials, Employees, …
Developer of high-end drug delivery solutions for nucleic acids and biologicals. The company develops a technology designed to enable the delivery of antisense and siRNA in vivo, as well …See details»
Novosom AG - VentureRadar
Find out more about Novosom AG, Healthtech and Life Sciences and Life Sciences.See details»
NovaSom - Crunchbase Company Profile & Funding
NovaSom, Inc. is a privately held diagnostic-service provider for home testing and evaluation of sleep-disordered breathing, which includes the diagnosis of obstructive sleep apnea (OSA). …See details»
Ercole and Novosom AG announce antisense delivery success
Mar 23, 2004 · Ercole Biotech, Inc., and novosom AG announced the successful completion of the first phase of their research collaboration. The research involves the intracellular targeted …See details»
Novosom - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Novosom is working with its partners to develop unique antisense, DNAi and siRNA.See details»
NovaSom Company Profile - Office Locations, Competitors ... - Craft
NovaSom has integrated their home sleep testing system into a cloud based, collaborative patient management platform for physicians and payers. See insights on NovaSom including office …See details»
ProNAi and Novosom Announce Collaboration to ... - Technology …
Mar 7, 2007 · ProNAi will license Novosom’s SMARTICLES® liposome technology to help advance PNT100 drug candidate toward IND, and to enable delivering nucleotides in vivo to …See details»
Novosom AG Acquires Exclusive License from Isis Pharmaceuticals …
Aug 26, 2008 · Novosom AG today announced that it has acquired an exclusive, worldwide license from Isis Pharmaceuticals to access certain antisense inhibitors targeting CD40 mRNA …See details»
IN BRIEF: BioSerenity to buy NovaSom out of bankruptcy
Sep 23, 2019 · NovaSom Inc, a bankrupt developer of a medical device used at home to record sleep apnea symptoms, said in a filing on Monday it is canceling its planned auction after …See details»
NovaSom Company Profile 2024: Valuation, Funding & Investors
Developer of home-testing services designed to provide continuous patient support. The company's home-testing services provides evaluation of sleep-disordered breathing, which …See details»
Novosom Acquires Exclusive Option for Antisense Inhibitors from …
Apr 11, 2007 · The option will provide the Novosom with a worldwide licence to antisense inhibitors targeting the CD40 membrane protein for all indications.See details»
NovaSom, Inc. Provides Home Sleep Testing Services for …
Feb 17, 2012 · NovaSom, Inc. is the market leader in obstructive sleep apnea (OSA) home testing, with the first FDA-cleared system and more than 10 years of experience in home sleep …See details»
VirtuOx Seeks to Acquire Substantially All Assets of NovaSom
On Aug 2, 2019, NovaSom Inc sought relief from its creditors under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. NovaSom is a …See details»
Novo: Make New
Choose from over 30 locations around the world to hear about people who have been awakened to their identity in Jesus and ability to hear his voice, equipped with tools to reach out to the …See details»
In the community - Novo Nordisk
Through partnerships with healthcare providers and not-for-profit organizations, we help drive research, advocacy and awareness initiatives to improve access to diabetes education, care …See details»
Novo Canada | Make New
Novo is a band of creative missionaries sent to multiply movements of the gospel and mobilize the church for mission around the world.See details»